PS Ratio Chart

View PS Ratio for MAHLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2009. Start Trial.
Date Value
June 10, 2026 0.1549
June 09, 2026 0.1549
June 08, 2026 0.1549
June 05, 2026 0.1549
June 04, 2026 0.1549
June 03, 2026 0.1549
June 02, 2026 0.1549
June 01, 2026 0.1549
May 29, 2026 0.1549
May 28, 2026 0.1549
May 27, 2026 0.1549
May 26, 2026 0.1549
May 22, 2026 0.1549
May 21, 2026 0.1549
May 20, 2026 0.1549
May 19, 2026 0.1549
May 18, 2026 0.1549
May 15, 2026 0.1549
May 14, 2026 0.1545
May 13, 2026 0.1545
May 12, 2026 0.1545
May 11, 2026 0.1545
May 08, 2026 0.1545
May 07, 2026 0.1558
May 06, 2026 0.1558
Date Value
May 05, 2026 0.1558
May 04, 2026 0.1558
May 01, 2026 0.1558
April 30, 2026 0.1558
April 29, 2026 0.1558
April 28, 2026 0.1558
April 27, 2026 0.1558
April 24, 2026 0.1558
April 23, 2026 0.1558
April 22, 2026 0.1558
April 21, 2026 0.1558
April 20, 2026 0.1558
April 17, 2026 0.1558
April 16, 2026 0.1558
April 15, 2026 0.1558
April 14, 2026 0.1558
April 13, 2026 0.1558
April 10, 2026 0.1558
April 09, 2026 0.1558
April 08, 2026 0.1558
April 07, 2026 0.1558
April 06, 2026 0.1558
April 02, 2026 0.1558
April 01, 2026 0.1558
March 31, 2026 0.1441

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Vital KSK Holdings, Inc. 0.1097
Suzuken Co., Ltd. 0.1307
Cencora, Inc. 0.1684
Cardinal Health, Inc. 0.2100
McKesson Corp. 0.2448

PS Ratio Related Metrics